Gregory Cartwright
Family Medicine · Fort Worth, TXNPI 1912957499
Payments from drug & device makers
Across 120 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$356
- Pfizer$204
- Collegium Pharmaceutical, Inc.$191
- GSK$155
- Bayer$143
- Lilly USA, LLC$116
- plus $923 from 23 others
What the payments were for
- Food & beverage$2,06799%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $356 |
| Pfizer | 13 | $204 |
| Collegium Pharmaceutical, Inc. | 10 | $191 |
| GSK | 8 | $155 |
| Bayer | 9 | $143 |
| Lilly USA, LLC | 7 | $116 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $105 |
| Amgen | 6 | $93 |
| AbbVie | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 5 | $77 |
| Azurity Pharmaceuticals, Inc. | 4 | $71 |
| Exact Sciences | 4 | $68 |
| AstraZeneca | 4 | $63 |
| Abbott | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $34 |
| Harmony Biosciences LLC | 1 | $27 |
| Astellas Pharma US Inc | 1 | $21 |
| Vertex | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Valinor Pharma, LLC | 1 | $19 |
| Medtronic | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Merck | 1 | $17 |
| Protega Pharmaceutials Inc | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Mission Pharmacal Company | 1 | $13 |
How this compares
$2,087 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 17 | $23,633 |
| OzempicSemaglutide | 21 | $22,610 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $17,748 |
| MounjaroTirzepatide | 14 | $14,785 |
| EliquisApixaban | 13 | $11,320 |
| PaxlovidNirmatrelvir/Ritonavir | 15 | $2,760 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $2,594 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 97 | $2,123 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 86 | $1,990 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 98 | $985 |
| Gabapentin | 51 | $612 |
| Atorvastatin Calcium | 48 | $511 |
| Trazodone Hcl | 37 | $454 |
| Alprazolam | 114 | $426 |
| Methocarbamol | 21 | $414 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $356 | $46,24338 claims |
| GSKTrelegy Ellipta | $155 | $17,74817 claims |
| Lilly USA, LLCMounjaro | $116 | $14,78514 claims |
| PfizerEliquis, Paxlovid | $204 | $14,08028 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Fort Worth
- William SegerFort Worth$27.5M
- Mark KochFort Worth$7.6M
- Isaac WatembergFort Worth$3.2M
- James HarveyFort Worth$2.7M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- Veronica FragosoHouston$24.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.